cladribine has been researched along with Leukemia, Prolymphocytic in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (66.67) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di Raimondo, F; Ferrajoli, A; Keating, MJ; Lerner, S; Montillo, M; Morra, E; O'Brien, S; Tedeschi, A | 1 |
| Robak, P; Robak, T | 1 |
| Agulló, JA; Domingo, JM; Palomera, L; Soledad Romero, M | 1 |
| Ellison, D; Jacobs, A; Lee, T; Longmire, R; Piro, L; Saven, A; Schlutz, M | 1 |
| Aranha, FJ; Lorand-Metze, I; Oliveira, GB | 1 |
| Polliack, A | 1 |
| Bassous, L; Berrebi, A; Klepfish, A; Shtalrid, M; Shvidel, L; Vorst, E | 1 |
| Cotelingam, JD; Glass, J; Nordberg, ML; Sattar, T; Veillon, DM | 1 |
| Barton, K; Larson, RA; O'Brien, S; Ratain, MJ | 1 |
2 review(s) available for cladribine and Leukemia, Prolymphocytic
| Article | Year |
|---|---|
Current treatment options in prolymphocytic leukemia.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Cladribine; Drug Therapy; Humans; Leukemia, Prolymphocytic; Pentostatin; Purine Nucleosides; Rituximab; Splenectomy; Stem Cell Transplantation; Vidarabine | 2007 |
Hairy cell leukemia and allied chronic lymphoid leukemias: current knowledge and new therapeutic options.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Cladribine; Diagnosis, Differential; Humans; Interferon-alpha; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Prolymphocytic; Lymphoma, Non-Hodgkin; Pentostatin; Prognosis | 1997 |
1 trial(s) available for cladribine and Leukemia, Prolymphocytic
| Article | Year |
|---|---|
Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemia.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cyclophosphamide; Disease-Free Survival; Female; Humans; Infusions, Intravenous; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Prolymphocytic; Leukopenia; Male; Middle Aged; Neoplasm Staging; Neutropenia; Salvage Therapy; Thrombocytopenia; Treatment Outcome | 2003 |
6 other study(ies) available for cladribine and Leukemia, Prolymphocytic
| Article | Year |
|---|---|
Complete remission in T-cell prolymphocytic leukemia with 2-chlorodeoxyadenosine.
Topics: Aged; Cladribine; Female; Humans; Leukemia, Prolymphocytic; Leukemia, T-Cell; Remission Induction | 1995 |
Major activity of cladribine in patients with de novo B-cell prolymphocytic leukemia.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cladribine; Drug Administration Schedule; Female; Humans; Leukemia, Prolymphocytic; Male; Middle Aged; Neoplasm Staging | 1997 |
Treatment of prolymphocytic leukemia with cladribine.
Topics: Aged; Antineoplastic Agents; Cladribine; Humans; Leukemia, Prolymphocytic; Male; Remission Induction | 1998 |
B-cell prolymphocytic leukemia: a survey of 35 patients emphasizing heterogeneity, prognostic factors and evidence for a group with an indolent course.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Immunophenotyping; Leukemia, B-Cell; Leukemia, Prolymphocytic; Lymphocytosis; Male; Middle Aged; Prognosis; Retrospective Studies; Splenomegaly; Survival Rate | 1999 |
Prolymphocytic leukemia or prolymphocytic transformation of mantle cell lymphoma.
Topics: Antigens, CD; Biomarkers, Tumor; Bone Marrow; Cell Transformation, Neoplastic; Cladribine; DNA, Neoplasm; Humans; Immunophenotyping; In Situ Hybridization, Fluorescence; Leukemia, B-Cell; Leukemia, Prolymphocytic; Lymphoma, Mantle-Cell; Male; Middle Aged | 2001 |
Rapid response of B-cell prolymphocytic leukemia to 2-chlorodeoxyadenosine.
Topics: Aged; Aged, 80 and over; Cladribine; Humans; Leukemia, B-Cell; Leukemia, Prolymphocytic; Male | 1992 |